Clinical Distribution Characteristics and Identification for Significant Liver Inflammation of Patients in Chronic Hepatitis B with Indeterminate Phase

Table 2

Baseline characteristics of patients with liver mild and significant inflammation in the indeterminate phase.

Variables	G0–1 ()	G2–4 ()	value
Age (year)	40.0 (34.0–47.0)	42.0 (33.0–49.0)	0.223
Sex (male%)	122 (60.4)	162 (67.8)	0.107
WBC (×10^9/L)	5.4 (4.5–6.5)	5.4 (4.5–6.6)	0.895
PLT (×10^9/L)	181.0 (153.0–220.3)	166.0 (138.0–206.0)	0.001
PT (s)	11.4 (11.0–11.9)	11.8 (11.2–12.3)	<0.001
INR	1.0 (1.0–1.1)	1.0 (1.0–1.1)	0.002
ALB (g/L)	45.4 (42.7–48.1)	44.2 (41.8–46.6)	0.003
GLB (g/L)	27.6 (25.5–30.9)	28.6 (25.6–32.0)	0.045
ALT (U/L)	27.0 (19.0–47.3)	40.0 (26.0–63.0)	<0.001
AST (U/L)	26.0 (21.0–32.5)	34.0 (26.0–45.0)	<0.001
GGT (U/L)	19.5 (14.0–30.0)	25.0 (18.0–43.0)	<0.001
ALP (U/L)	75.5 (60.8–91.0)	81.0 (62.0–99.0)	0.052
TBIL (μmol/L)	13.0 (10.0–17.2)	14.3 (11.0–18.9)	0.155
Log10 (HBV-DNA IU/ml)	4.2 (3.6–4.9)	4.5 (3.9–5.5)	0.002
Log10 (HBsAg IU/ml)	2.4 (2.4–3.3)	2.4 (2.4–3.3)	0.536
Anti-HBC (S/CO)	11.2 (9.5–12.3)	11.2 (9.8–12.5)	0.493
Fibrosis (%)
0	56 (27.7)	11 (4.6)	<0.001
1	100 (49.5)	61 (25.5)
2	38 (18.8)	84 (35.1)
3	7 (3.5)	41 (17.2)
4	1 (0.5)	42 (17.6)